CAS NO: | 1884222-74-5 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 |
SBP-7455 is a potent, high affinity and orally active dualULK1/ULK2autophagy inhibitorwithIC50s of 13 nM and 476 nM in the ADP-Glo assays, respectively. SBP-7455 potently inhibitsULK1/2enzymatic activity and can be used for triple-negative breastcancer(TNBC) research[1]. |
||||||||||||||||
IC50& Target |
|
||||||||||||||||
体外研究 (In Vitro) |
SBP-7455 (compound 26; 72 h) treatment inhibits cell growth with an IC50of 0.3 μM for MDA-MB-468 cells. SBP-7455 inhibits starvation-induced autophagic flux in TNBC cells that are dependent on autophagy for survival[1].
|
||||||||||||||||
体内研究 (In Vivo) |
A single dose of SBP-7455 (compound 26) (30 mg/kg) is orally administered to mice. The Tmaxfor SBP-7455 is approximately 1 h, the Cmaxis 990 nM and the T1/2is 1.7 h. The plasma concentration of SBP-7455 remains above the ULK1 IC50for almost 4 h after oral dosing[1].
|
||||||||||||||||
分子量 |
354.33 |
||||||||||||||||
性状 |
Solid |
||||||||||||||||
Formula |
C16H17F3N4O2 |
||||||||||||||||
CAS 号 |
1884222-74-5 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 125 mg/mL(352.78 mM;Need ultrasonic)
配制储备液
*
请根据半岛bd体育手机客户端 在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的半岛bd体育手机客户端 失效。
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*
以上所有助溶剂都可在本网站选购。
|